Nuoyu Pharmaceutical is a medical innovative drug developer, focusing on cutting-edge nuclear drug research and development and innovative drug screening. The company takes nuclear medicine product development and service as its main business direction, and is committed to solving unmet clinical needs in major diseases such as kidney cancer and gastric cancer. Recently, Nuoyu Pharmaceutical has completed tens of millions of yuan in Pre-A round of financing. This financing is led by the old shareholder Xinghua Dingli Capital, with additional investment from Zhuhai Bairui Hengsheng, which will further consolidate the foundation of Nuoyu Pharmaceutical’s nuclear medicine innovation platform and promote the rapid development of the industrial layout.
This article is reproduced from: https://www.itjuzi.com/investevent/13352885
This site is for inclusion only, and the copyright belongs to the original author.